# OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS

> **NCT06546410** · — · NOT_YET_RECRUITING · sponsor: **Neuronostics Ltd** · enrollment: 500 (estimated)

## Conditions studied

- Epilepsy
- Epilepsy in Children

## Interventions

- **DEVICE:** BioEP

## Key facts

- **NCT ID:** NCT06546410
- **Lead sponsor:** Neuronostics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-07-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546410, "OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06546410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*